 - 95 complete response rate after single dose of CDX-0159 - - Rapid, profound and durable responses offer patients opportunity for quick, lasting, meaningful relief - - Median duration of response 77 days in Cold Urticaria and 57 days in Symptomatic Dermographism - - Serum tryptase and skin mast cell depletion mirror clinical activity - - Favorable safety profile - - Company to host webcast conference call on Monday, July 12 at 8:15 a.m. ET - 